Skip to content

Insider · CIK 0001557930

Georgia Erbez

cfoofficerdirector

Files at CDXS (CODEXIS, INC.), CHRS (Coherus Oncology, Inc.). First filing Oct 15, 2025, latest Oct 15, 2025.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 1
$0 bought, $16k sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

CDXS: CODEXIS, INC.

CDXSOct 9, 2026 · close 1.41

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
30Weak
CDXSsell 2
CODEXIS, INC.
$16k
6,239 shares
-8%+27% from low-57% from high

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Oct 13, 2025CDXS
CODEXIS, INC.
SOpen-market sale
Common Stock
-6,239$2.51$16k70,636Oct 15, 2025
Jun 12, 2025CHRS
Coherus Oncology, Inc.
AGrant or award
Stock Option (Right to Buy)derivative
+112,000$0.00$0112,000Jun 13, 2025
Feb 5, 2025CDXS
CODEXIS, INC.
AGrant or award
Common Stock
+26,875$0.00$076,875Feb 7, 2025
Feb 5, 2025CDXS
CODEXIS, INC.
AGrant or award
Stock Option (Right to Buy)derivative
+161,250$0.00$0161,250Feb 7, 2025

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Georgia Erbez: insider trades and track record | InsiderTell